TABLE OF CONTENTS
Volume 32, Issue 5 (September (1) 2003)
Mini Review |
Conditioning Regimens |
Neuroblastoma |
Breast Cancer |
Donor Lymphocyte Infusions |
Graft-Versus-Host Disease |
Infections Post Transplant |
Post-Transplant Complications |
Post Transplant Lymphoproliferative Disorder |
Case Report |
Correspondence
Editorial
Donor leukaemia: perhaps a more common occurrence than we thought! FREE
S McCann and E Wright
Bone Marrow Transplant 32: 455-457; doi:10.1038/sj.bmt.1704218
Mini Review
Transplantation for chronic myelogenous leukemia: yes, no, maybe so...an Oregon perspective FREE
Richard T Maziarz and Michael J Mauro
Bone Marrow Transplant 32: 459-469; doi:10.1038/sj.bmt.1704163
Conditioning Regimens
Regimen-related toxicity after fludarabine–melphalan conditioning: a prospective study of 31 patients with hematologic malignancies FREE
K van Besien, S Devine, A Wickrema, E Jessop, K Amin, M Yassine, V Maynard, W Stock, D Peace, F Ravandi, Y-H Chen, R Hoffman and J Sossman
Bone Marrow Transplant 32: 471-476; doi:10.1038/sj.bmt.1704166
Fractionated TBI correlates with less T cell mixed chimerism but increased risk of relapse compared to busulphan in patients with haematological malignancies after allogeneic stem cell transplantation FREE
J Mattsson, M Uzunel, M Remberger and M Hassan
Bone Marrow Transplant 32: 477-483; doi:10.1038/sj.bmt.1704154
Neuroblastoma
Ex vivo expansion of autologous PB CD34+ cells provides a purging effect in children with neuroblastoma FREE
J Kanold, P Halle, A Tchirkov, M Berger, M C Giarratana, L Kobari, N Boiret, C Paillard, F Deméocq and L Douay
Bone Marrow Transplant 32: 485-488; doi:10.1038/sj.bmt.1704189
Breast Cancer
Autologous hematopoietic stem cell transplantation for breast cancer in Europe: critical evaluation of data from the European Group for Blood and Marrow Transplantation (EBMT) Registry 1990–1999 FREE
P Pedrazzoli, P Ferrante, A Kulekci, R Schiavo, U De Giorgi, O Carminati, M Marangolo, T Demirer, S Siena and G Rosti on behalf of the European Group for Blood and Marrow Transplantation (EBMT), Solid Tumors Working Party
Bone Marrow Transplant 32: 489-494; doi:10.1038/sj.bmt.1704153
Donor Lymphocyte Infusions
Allogeneic cell-mediated immunotherapy of leukemia with immune donor lymphocytes to upregulate antitumor effects and downregulate antihost responses FREE
Y H Ji, L Weiss, M Zeira, A Abdul-Hai, S Reich, L Schuger and S Slavin
Bone Marrow Transplant 32: 495-504; doi:10.1038/sj.bmt.1704150
Graft-Versus-Host Disease
Influence of transplanted dose of CD56+ cells on development of graft-versus-host disease in patients receiving G-CSF-mobilized peripheral blood progenitor cells from HLA-identical sibling donors FREE
S Yamasaki, H Henzan, Y Ohno, T Yamanaka, T Iino, Y Itou, M Kuroiwa, M Maeda, N Kawano, N Kinukawa, T Miyamoto, K Nagafuji, K Shimoda, S Inaba, S Hayashi, S Taniguchi, T Shibuya, H Gondo, T Otsuka and M Harada for Fukuoka Blood and Marrow Transplantation Group
Bone Marrow Transplant 32: 505-510; doi:10.1038/sj.bmt.1704165
Severe acute graft-versus-host disease after T-cell depleted allogeneic stem cell graft from a second donor caused by persisting T-cells from the first donor FREE
A Wiesmann, P Bader, M Bamberg, C Faul, L Kanz and H Einsele
Bone Marrow Transplant 32: 511-513; doi:10.1038/sj.bmt.1704170
Infections Post Transplant
Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation FREE
Chien-Shing Chen, M Boeckh, K Seidel, J G Clark, E Kansu, D K Madtes, J L Wagner, R P Witherspoon, C Anasetti, F R Appelbaum, W I Bensinger, H J Deeg, P J Martin, J E Sanders, R Storb, J Storek, J Wade, M Siadak, M E D Flowers and K M Sullivan
Bone Marrow Transplant 32: 515-522; doi:10.1038/sj.bmt.1704162
Post-Transplant Complications
FK506-associated limbic injury following umbilical cord blood transplantation FREE
Y Yoshida, H Shimada, T Mori, H Yoshihara, M Takeoka and T Takahashi
Bone Marrow Transplant 32: 523-525; doi:10.1038/sj.bmt.1704168
Post Transplant Lymphoproliferative Disorder
Effect of in vivo lymphocyte-depleting strategies on development of lymphoproliferative disorders in children post allogeneic bone marrow transplantation FREE
B A Lynch, M A Vasef, M Comito, A L Gilman, N Lee, J Ritchie, S Rumelhart, M Holida and F Goldman
Bone Marrow Transplant 32: 527-533; doi:10.1038/sj.bmt.1704159
Case Report
Syngeneic graft-versus-host disease: a report of two cases and literature review FREE
T Latif, B Pohlman, M Kalaycio, R Sobecks, E D Hsi, S Andresen and B J Bolwell
Bone Marrow Transplant 32: 535-539; doi:10.1038/sj.bmt.1704171
Correspondence
Successful unrelated allogeneic stem cell transplantation after treatment of lymphoid blast crisis CML with imatinib and imatinib-containing conditioning regimen in a 16-year-old male FREE
M Koch, P Lang, P Bader, H Kreyenberg, M Schumm, H Scheel-Walter, A Hochhaus, D Niethammer and J Greil
Bone Marrow Transplant 32: 541-542; doi:10.1038/sj.bmt.1704167
